- Tytuł:
- Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology October 2019 20(10):1444-1453
Czasopismo naukowe